Viewing Study NCT01989468


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-04-12 @ 7:19 PM
Study NCT ID: NCT01989468
Status: COMPLETED
Last Update Posted: 2019-04-16
First Post: 2013-11-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis
Sponsor: Novartis Pharmaceuticals
Organization: